Skip to main content
. 2015 Jul 17;6(28):25988–26001. doi: 10.18632/oncotarget.4620

Figure 6. Downregulation of c-Myc protein expression in bortezomib-treated human Burkitt's lymphoma cells.

Figure 6

(A, B) Daudi cells were treated with various concentrations of bortezomib (Bz), or with 10 nM bortezomib for the indicated periods. A. Total RNA was extracted to detect mRNA expression by RT-PCR, and B. total cellular proteins were collected to detect protein expression by western blotting.